Paris, France · Founded 2008 · Privately Held (backing)
Developer of pharmaceuticals and diagnostic tests designed for developing off-the-shelf, transformational cancer treatments targeting all tumor types. Enterome is based in Paris, France and was founded in 2008. Its last reported valuation was $217 million in Jul 2022. It has raised $292 million.
Last reported valuation
$217.0M
Oct 2026
Priced at
—
Total raised
$292.3M
Last round
—
Cap table — not yet on record
Enterome's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Enterome with a free account
·The complete investor list: 18 names
·Watch Enterome: the Monday email on marks, rounds and moves
